Published in J Neuroimmune Pharmacol on November 19, 2008
Exercise Training to Improve Brain Health in Older HIV+ Individuals (Ex/HIV) | NCT02663934
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology (2014) 3.15
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci (2013) 1.65
Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol (2011) 1.29
Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesis. AIDS Behav (2011) 1.27
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol (2014) 1.11
Editorial neuroAIDS review. AIDS (2011) 1.10
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders. Mol Brain (2011) 1.08
Infectious agents and neurodegeneration. Mol Neurobiol (2012) 1.03
11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol (2012) 1.00
HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin. Mol Cell Neurosci (2009) 0.95
Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier. IUBMB Life (2012) 0.91
Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence. Curr HIV/AIDS Rep (2014) 0.91
Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol (2014) 0.90
Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production. Neurobiol Aging (2013) 0.89
HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci Lett (2010) 0.87
HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes. J Immunol (2011) 0.86
HIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-β/Smad signaling. Exp Cell Res (2014) 0.82
Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond. Nucl Med Commun (2014) 0.81
Lipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells. Biochem Biophys Res Commun (2012) 0.81
RNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic rats. PLoS One (2013) 0.81
Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1. Scientifica (Cairo) (2013) 0.80
The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model. J Neuroimmune Pharmacol (2011) 0.80
Ketone bodies protection against HIV-1 Tat-induced neurotoxicity. J Neurochem (2012) 0.80
Neurodegenerative effects of recombinant HIV-1 Tat(1-86) are associated with inhibition of microtubule formation and oxidative stress-related reductions in microtubule-associated protein-2(a,b). Neurochem Res (2011) 0.80
Pivotal role of RIP1 and MLKL in neuronal cell death induced by the human neuroinvasive coronavirus OC43. J Virol (2016) 0.77
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda. J Neurovirol (2016) 0.76
Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis. AIDS (2015) 0.75
Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals. PLoS One (2016) 0.75
Transcriptional profile of HIV-induced nuclear translocation of amyloid β in brain endothelial cells. Arch Med Res (2014) 0.75
HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. Am J Pathol (2017) 0.75
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview. Front Microbiol (2016) 0.75
Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation. J Neuroimmune Pharmacol (2016) 0.75
Effect of coadministration of neurovite and Lamivudine on the histomorphology of the cerebellum of wistar rats. ISRN Neurosci (2014) 0.75
Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology. Mol Cell Neurosci (2016) 0.75
Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV. Curr HIV/AIDS Rep (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell (1996) 8.89
Synaptic scaling mediated by glial TNF-alpha. Nature (2006) 6.76
The neuropathogenesis of AIDS. Nat Rev Immunol (2005) 6.54
Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med (2006) 6.15
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A (1989) 5.97
Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol (2004) 5.71
Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature (2001) 5.60
Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci (2000) 5.57
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A (2003) 5.44
Semen-derived amyloid fibrils drastically enhance HIV infection. Cell (2007) 5.23
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem (1987) 4.99
Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol (2005) 4.91
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Control of synaptic strength by glial TNFalpha. Science (2002) 4.46
Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature (1995) 4.18
Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron (2003) 4.11
Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci (2008) 3.90
Interleukin-1 and neuronal injury. Nat Rev Immunol (2005) 3.85
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol (2002) 3.23
Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology (1992) 3.15
Decline in deaths from AIDS due to new antiretrovirals. Lancet (1997) 3.13
Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc (2005) 3.07
Exosomes are released by cultured cortical neurones. Mol Cell Neurosci (2006) 3.07
HIV infection and dementia. Science (2000) 3.03
HIV dementia: an evolving disease. J Neuroimmunol (2004) 2.88
Clearing the brain's amyloid cobwebs. Neuron (2001) 2.87
Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science (1990) 2.87
GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat Med (1995) 2.77
HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ (2005) 2.54
Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest (2007) 2.48
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A (2008) 2.38
Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci (2003) 2.35
Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34
Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med (2007) 2.32
Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci U S A (2006) 2.31
Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol (2007) 2.27
Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol (2008) 2.26
Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res (2005) 2.09
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (2005) 2.07
Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol (2007) 2.05
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 1.98
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc Natl Acad Sci U S A (2004) 1.98
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia (2008) 1.97
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol (2006) 1.94
Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol (2005) 1.94
beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem (2001) 1.92
Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol (2007) 1.90
Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol (2005) 1.90
Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science (1999) 1.88
Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem (2004) 1.88
Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis (2002) 1.85
Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem (1995) 1.83
Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse (2000) 1.82
Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc Natl Acad Sci U S A (2006) 1.81
"Inflammatory" cytokines: neuromodulators in normal brain? J Neurochem (2000) 1.80
Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci (1998) 1.80
Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS (2002) 1.78
Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci (2007) 1.77
Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol (2005) 1.77
The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem (2006) 1.76
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol (2006) 1.69
Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr Alzheimer Res (2007) 1.68
The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci (2005) 1.68
CNS injury: the role of the cytokine IL-1. Vet J (2004) 1.65
Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry (1998) 1.62
Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest (2006) 1.58
Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging (1997) 1.56
Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med (2007) 1.55
Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res (2007) 1.54
Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat Med (2000) 1.53
Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol (2005) 1.53
Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem (2005) 1.53
Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus (2003) 1.52
Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol (2006) 1.52
The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol (2003) 1.51
The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J (2007) 1.50
Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol (1999) 1.49
HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host Microbe (2007) 1.47
HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS (2005) 1.47
Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database. AIDS (2001) 1.45
NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci (2005) 1.44
Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol (2005) 1.43
Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care STDS (2007) 1.41
Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol (1998) 1.41
The shifting patterns of HIV encephalitis neuropathology. Neurotox Res (2005) 1.36
The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci (2000) 1.36
Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J Biol Chem (1996) 1.35
The neuropathogenesis of the AIDS dementia complex. AIDS (1997) 1.34
Macrophages and HIV-1: dangerous liaisons. Mol Immunol (2005) 1.31
Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav Brain Res (2001) 1.30
Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun (1995) 1.28
Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol (2008) 1.27
Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med (2012) 6.27
The spectrum of disease in chronic traumatic encephalopathy. Brain (2012) 5.10
Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol (2007) 2.05
Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood (2006) 1.85
Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am J Pathol (2008) 1.55
Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition. Am J Pathol (2005) 1.46
Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies. J Neurosci (2012) 1.34
CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J (2010) 1.25
Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. J Immunol (2008) 1.23
The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch Immunol Ther Exp (Warsz) (2012) 1.23
CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. PLoS One (2009) 1.21
Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation. J Neurochem (2006) 1.19
Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLoS One (2013) 1.09
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J Immunol (2007) 1.07
Molecular characterization of a putative antiretroviral transcriptional factor, OTK18. J Immunol (2004) 1.02
FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders. Proc Natl Acad Sci U S A (2011) 1.00
AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Mol Ther (2009) 0.98
TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation. J Immunol (2006) 0.94
Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models. Am J Pathol (2013) 0.93
Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. J Neurosci (2008) 0.93
OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions. J Gen Virol (2007) 0.92
C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. J Neuroimmunol (2003) 0.91
OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. J Neuroimmunol (2004) 0.91
Polyfluorinated bis-styrylbenzene beta-amyloid plaque binding ligands. J Med Chem (2007) 0.90
Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. J Neuroimmune Pharmacol (2013) 0.89
Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice. FASEB J (2010) 0.88
Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease? J Alzheimers Dis (2012) 0.86
HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes. J Immunol (2011) 0.86
Kinetic analysis of aggregated amyloid-beta peptide clearance in adult bone-marrow-derived macrophages from APP and CCL2 transgenic mice. J Neuroimmune Pharmacol (2006) 0.86
Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes. PLoS One (2009) 0.81
PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. Ann Neurol (2014) 0.81
Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity. J Neurochem (2011) 0.81
Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages: implications for the pathogenesis of Alzheimer's disease. Neurobiol Aging (2004) 0.80
The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model. J Neuroimmune Pharmacol (2011) 0.80
The neuropathogenesis of HIV-1 infection. Handb Clin Neurol (2007) 0.79
OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients. J Neuroimmune Pharmacol (2008) 0.78
Distinct neuronal localization of microtubule-associated protein 4 in the mammalian brain. Neurosci Lett (2010) 0.78
YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection. J Neuroimmune Pharmacol (2008) 0.78
Phenolic bis-styrylbenzenes as β-amyloid binding ligands and free radical scavengers. J Med Chem (2010) 0.77
Transduction of bovine adrenal chromaffin cells using a recombinant adenovirus expressing GFP. J Neurosci Methods (2002) 0.77
Betagamma subunits mediate the NPY enhancement of ATP-stimulated inositol phosphate formation. Peptides (2004) 0.77
Neuroimmune pharmacology as a sub-discipline of medical neuroscience in the medical school curriculum. J Neuroimmune Pharmacol (2010) 0.76
Calpain and proteasomal regulation of antiretroviral zinc finger protein OTK18 in human macrophages: visualization in live cells by intramolecular FRET. J Neuroimmune Pharmacol (2008) 0.75